The Filings Report

Tenet Healthcare Corporation New

THCNYSECIK 70318Healthcare / Healthcare Providers & Servicesfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$5.6B
+6.5% on Q3 FY2025
Net income
—
no year-earlier figure
Free cash flow
$1.1B
+39.2% on Q3 FY2025
Diluted EPS
$12.41
+221.5% on Q3 FY2025
Revenue, TTM
$22.2B
trailing four quarters
Net margin, TTM
—
net income —
Free cash flow, TTM
$3.3B
$4.2B less $910M capex
Cash and equivalents
$2.7B
long-term debt —, Sep 30, 2026
Shares, 12-month change
−9.4%
80M shares, Sep 30, 2026
Buybacks, TTM
$1.8B
8.3% of market value
Dividends, TTM
—
no yield
Market value
$21.7B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Tenet Healthcare Corporation New reported revenue of $5.6B, +6.5% on Q3 FY2025. Operating margin was 31.1%. Free cash flow, operating cash flow less capital expenditures, was $1.1B ($1.3B less $198M). Diluted earnings per share were $12.41.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6BQ4'22, Revenue: $5.0BQ4'22Q1'23, Revenue: $5.0BQ1'23Q2'23, Revenue: $5.1BQ2'23Q3'23, Revenue: $5.1BQ3'23Q4'23, Revenue: $5.4BQ4'23Q1'24, Revenue: $5.4BQ1'24Q2'24, Revenue: $5.1BQ2'24Q3'24, Revenue: $5.1BQ3'24Q4'24, Revenue: $5.1BQ4'24Q1'25, Revenue: $5.2BQ1'25Q2'25, Revenue: $5.3BQ2'25Q3'25, Revenue: $5.3BQ3'25Q4'25, Revenue: $5.5BQ4'25Q1'26, Revenue: $5.4BQ1'26Q2'26, Revenue: $5.6BQ2'26Q3'26, Revenue: $5.6BQ3'26$0$2B$4B$6BQ4'22, Revenue: $5.0BQ1'23, Revenue: $5.0BQ1'23Q2'23, Revenue: $5.1BQ3'23, Revenue: $5.1BQ3'23Q4'23, Revenue: $5.4BQ1'24, Revenue: $5.4BQ1'24Q2'24, Revenue: $5.1BQ3'24, Revenue: $5.1BQ3'24Q4'24, Revenue: $5.1BQ1'25, Revenue: $5.2BQ1'25Q2'25, Revenue: $5.3BQ3'25, Revenue: $5.3BQ3'25Q4'25, Revenue: $5.5BQ1'26, Revenue: $5.4BQ1'26Q2'26, Revenue: $5.6BQ3'26, Revenue: $5.6BQ3'26

Net income losses drawn in red.

Free cash flow
−$1B$0$1B$2BQ4'22, Free cash flow: $131MQ4'22Q1'23, Free cash flow: $214MQ1'23Q2'23, Free cash flow: $466MQ2'23Q3'23, Free cash flow: $327MQ3'23Q4'23, Free cash flow: $616MQ4'23Q1'24, Free cash flow: $346MQ1'24Q2'24, Free cash flow: $602MQ2'24Q3'24, Free cash flow: $829MQ3'24Q4'24, Free cash flow: −$661MQ4'24Q1'25, Free cash flow: $642MQ1'25Q2'25, Free cash flow: $743MQ2'25Q3'25, Free cash flow: $778MQ3'25Q4'25, Free cash flow: $367MQ4'25Q1'26, Free cash flow: $1.5BQ1'26Q2'26, Free cash flow: $417MQ2'26Q3'26, Free cash flow: $1.1BQ3'26−$1B$0$1B$2BQ4'22, Free cash flow: $131MQ1'23, Free cash flow: $214MQ1'23Q2'23, Free cash flow: $466MQ3'23, Free cash flow: $327MQ3'23Q4'23, Free cash flow: $616MQ1'24, Free cash flow: $346MQ1'24Q2'24, Free cash flow: $602MQ3'24, Free cash flow: $829MQ3'24Q4'24, Free cash flow: −$661MQ1'25, Free cash flow: $642MQ1'25Q2'25, Free cash flow: $743MQ3'25, Free cash flow: $778MQ3'25Q4'25, Free cash flow: $367MQ1'26, Free cash flow: $1.5BQ1'26Q2'26, Free cash flow: $417MQ3'26, Free cash flow: $1.1BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ4'22, Cash and equivalents: $858MQ4'22Q1'23, Cash and equivalents: $766MQ1'23Q2'23, Cash and equivalents: $934MQ2'23Q3'23, Cash and equivalents: $1.1BQ3'23Q4'23, Cash and equivalents: $1.2BQ4'23Q1'24, Cash and equivalents: $2.5BQ1'24Q2'24, Cash and equivalents: $2.9BQ2'24Q3'24, Cash and equivalents: $4.1BQ3'24Q4'24, Cash and equivalents: $3.0BQ4'24Q1'25, Cash and equivalents: $3.0BQ1'25Q2'25, Cash and equivalents: $2.6BQ2'25Q3'25, Cash and equivalents: $3.0BQ3'25Q4'25, Cash and equivalents: $2.9BQ4'25Q1'26, Cash and equivalents: $3.0BQ1'26Q2'26, Cash and equivalents: $2.2BQ2'26Q3'26, Cash and equivalents: $2.7BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $858MQ1'23, Cash and equivalents: $766MQ1'23Q2'23, Cash and equivalents: $934MQ3'23, Cash and equivalents: $1.1BQ3'23Q4'23, Cash and equivalents: $1.2BQ1'24, Cash and equivalents: $2.5BQ1'24Q2'24, Cash and equivalents: $2.9BQ3'24, Cash and equivalents: $4.1BQ3'24Q4'24, Cash and equivalents: $3.0BQ1'25, Cash and equivalents: $3.0BQ1'25Q2'25, Cash and equivalents: $2.6BQ3'25, Cash and equivalents: $3.0BQ3'25Q4'25, Cash and equivalents: $2.9BQ1'26, Cash and equivalents: $3.0BQ1'26Q2'26, Cash and equivalents: $2.2BQ3'26, Cash and equivalents: $2.7BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Tenet Healthcare Corporation New income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 30, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue5,6315,6285,3685,5275,2895,2715,2235,073+6.5%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income1,7501,5011,296853889823943821+96.9%
Other income (expense)3743413729252637+27.6%
Pretax income—1,3401,132681712642765655—
Income tax3602952263713312014383+170.7%
Net income—————————
Diluted EPS ($)12.419.848.01—3.863.144.27—+221.5%
Diluted shares (millions)818488—899295——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Tenet Healthcare Corporation New balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 30, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents2,6742,1702,9672,8832,9752,6252,9993,019−10.1%
Short-term investments—————————
Total current assets8,4287,8278,3567,8497,8107,2987,9137,682+7.9%
Total assets31,59230,67631,20329,67729,41828,69929,23728,936+7.4%
Total current liabilities5,3185,5676,1524,4634,5604,2714,4514,310+16.6%
Long-term debt—————————
Total liabilities21,99821,97622,35320,70420,71820,39720,58420,389+6.2%
Stockholders’ equity5,4444,6584,8144,2204,0143,7494,1814,171+35.6%
Shares outstanding (millions)8081868788889395—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Tenet Healthcare Corporation New cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 30, 2025Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow1,2815851,6417311,058936815(331)+21.1%
Capital expenditures198168180364280193173330−29.3%
Free cash flow (CFO − capex)1,0834171,461367778743642(661)+39.2%
Depreciation and amortization217215229231218208206193−0.5%
Share repurchases2551,042318198937473480+174.2%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 17, 2026.

Income statement

Tenet Healthcare Corporation New income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 24, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 26, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Revenue21,31020,67520,56419,17419,48517,64018,47918,31320,61321,070————————
Cost of revenue——————————————————
Gross profit——————————————————
Research and development——————————————————
Selling, general and administrative——————————————————
Operating income3,5085,9562,5102,3332,8711,9891,5371,6371,1131,2471,077925663749653634538311
Other income (expense)1171261911141(5)(5)——————————
Pretax income2,8005,2481,6171,3451,888671320629(101)248144147(158)334164158205—
Income tax4331,184306344411(97)160173219676849(65)12561(977)(23)(25)
Net income———————————————1,11918125
Diluted EPS ($)15.4932.705.713.798.423.75(2.08)1.00(7.00)(1.93)(1.41)0.12(1.32)1.300.488.161.48*0.20*
Diluted shares (millions)91981051111091061031041019999100102109121140127*120*

Balance sheet

Tenet Healthcare Corporation New balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 24, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 26, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Cash and equivalents2,8833,0191,2288582,3642,446262411611716356193113364113405690507
Short-term investments————————————14—011—
Total current assets7,8497,6827,1675,9817,0757,1475,0814,6365,5735,2575,1713,9703,6922,6812,3572,3112,472—
Total assets29,67728,93628,31227,15627,57927,10623,36522,43023,38524,70123,68217,95116,4509,0448,4628,5007,953—
Total current liabilities4,4634,3104,7604,4765,1094,8474,2053,8574,3324,0344,3083,5773,0931,7631,8151,7251,783—
Long-term debt———————————————3,997——
Total liabilities20,70420,38922,80422,54823,32224,21721,42220,30220,98021,22620,45816,76515,2327,8106,9546,6817,256—
Stockholders’ equity4,2204,1711,6081,1421,02828(417)(119)(147)4176916517551,1431,4231,766646—
Shares outstanding (millions)8795100102107106104103101100999897104102*121*——

Cash flow statement

Tenet Healthcare Corporation New cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 24, 2020FY2018ended Dec 31, 2018filed Feb 25, 2019FY2017ended Dec 31, 2017filed Feb 26, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 24, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Operating cash flow3,5402,0472,3741,0831,5683,4071,2331,0491,2005581,026687589593497472425208
Capital expenditures1,010931751762658540670617707875842933691506467———
Free cash flow (CFO − capex)2,5301,1161,6233219102,867563432493(317)184(246)(102)8730———
Depreciation and amortization863818870841855857850802870850797849545430398380386371
Share repurchases1,38667220025000——0040—40012637400—
Dividends paid——————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$43M
15 sales by 8 insiders; officers and directors $43M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$71M
42 sales by 13 insiders; officers and directors $71M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 14, 2026Kerrey J RobertDirectoropen-market sale5,483$263.04$1M11,321Sep 16, 2026
Sep 14, 2026Kerrey J RobertDirectoropen-market sale4,025$264.10$1M7,296Sep 16, 2026
Sep 14, 2026Kerrey J RobertDirectoropen-market sale2,502$264.62$662K4,794Sep 16, 2026
Sep 10, 2026Mark Richard JDirectoropen-market sale10,000$263.42$3M25,121Sep 14, 2026
Sep 2, 2026West NadjaDirectoropen-market sale1,152$258.80$298K23,653Sep 3, 2026
Aug 31, 2026Foo Lisa YEVP, Chief Operating Officeropen-market sale24,000$266.32$6M8,053Sep 1, 2026
Aug 28, 2026Haney Cecil DDirectorgift150$0.00—12,403Aug 31, 2026
Aug 25, 2026Sutaria SaumyaCEO, Directoropen-market sale17,220$273.34$5M466,344Aug 26, 2026
Aug 25, 2026Sutaria SaumyaCEO, Directoropen-market sale24,881$274.10$7M441,463Aug 26, 2026
Aug 25, 2026Sutaria SaumyaCEO, Directoropen-market sale7,899$275.26$2M433,564Aug 26, 2026
Aug 24, 2026Haney Cecil DDirectoropen-market sale1,300$278.03$361K12,553Aug 26, 2026
Aug 24, 2026Sutaria SaumyaCEO, Directoropen-market sale13,344$278.17$4M520,220Aug 26, 2026
Aug 24, 2026Sutaria SaumyaCEO, Directoropen-market sale36,656$278.90$10M483,564Aug 26, 2026
Aug 7, 2026Romo TammyDirectoropen-market sale2,500$260.83$652K28,284Aug 10, 2026
Aug 6, 2026Romo TammyDirectoropen-market sale4,922$264.15$1M30,784Aug 10, 2026
Aug 5, 2026Blunt RoyDirectoropen-market sale600$262.68$158K4,589Aug 7, 2026
Jul 29, 2026Foo Lisa YEVP, Chief Operating Officeropen-market sale10,000$258.03$3M32,053Jul 31, 2026
Jul 27, 2026Lynch Christopher S.Directoropen-market sale3,837$243.44$934K9,568Jul 28, 2026
Jul 27, 2026Arbour Paola MEVP, Chief Information Officeropen-market sale10,878$243.90$3M18,413Jul 28, 2026
Jul 27, 2026Bierman James LDirectoropen-market sale5,000$244.96$1M31,604Jul 28, 2026
May 28, 2026Kerrey J RobertDirectoropen-market sale1,969$173.12$341K20,473May 29, 2026
May 28, 2026Kerrey J RobertDirectoropen-market sale1,690$173.97$294K18,783May 29, 2026
May 28, 2026Kerrey J RobertDirectoropen-market sale713$175.13$125K18,070May 29, 2026
May 28, 2026Kerrey J RobertDirectoropen-market sale905$176.89$160K17,165May 29, 2026
May 28, 2026Kerrey J RobertDirectoropen-market sale361$177.52$64K16,804May 29, 2026

Full insider history for Tenet Healthcare Corporation New, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
TENET HEALTHCARE CORP, CIK 70318 on EDGAR
Extract generated
November 1, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: income tax FY2011, pretax income FY2011, revenue FY2017
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/THC.json